Question 1

How many shares of BBIO does Rafferty Asset Management, LLC own?

Accepted Answer

As of 2026-Q2, Rafferty Asset Management, LLC holds 40,953 shares of BBIO (BRIDGEBIO PHARMA INC).

Question 2

What is Rafferty Asset Management, LLC's BBIO position worth?

Accepted Answer

As of 2026-Q2, Rafferty Asset Management, LLC's BBIO position is worth $3.1M.

Question 3

Is Rafferty Asset Management, LLC buying or selling BBIO?

Accepted Answer

In 2026-Q2, Rafferty Asset Management, LLC decreased their BBIO position (-35.2% change in shares).

Question 4

When did Rafferty Asset Management, LLC first buy BBIO?

Accepted Answer

Based on available 13F filings, Rafferty Asset Management, LLC first reported a position in BBIO in 2024-Q3. They have held the position across 27 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	40,953	-35.2%	$3.1M	0.0%	$74.48	0
2026-Q1	Decreased	63,180	-21.0%	$4.7M	0.0%	$74.26	0
2025-Q4	Decreased	80,018	-47.4%	$6.1M	0.0%	$76.49	0
2025-Q3	Decreased	151,990	-22.8%	$7.9M	0.0%	$51.94	0
2025-Q2	Decreased	196,782	-2.6%	$8.5M	0.0%	$43.18	0
2025-Q1	Decreased	202,128	-19.2%	$7M	0.0%	$34.57	0
2024-Q4	Increased	250,242	+2.8%	$6.9M	0.0%	$27.44	28
2024-Q3	Decreased	243,331	-10.4%	$6.2M	0.0%	$25.46	0